Syros Garners $30,000,000 Series A Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fd3b4656-370a-4fc5-b0b5-ec01fe9b14bb&Preview=1 - Date
4/12/2013 - Company Name
Syros - Mailing Address
480 Arsenal Street Watertown, MA 02472 - Company Description
Syros Pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. Syros has pioneered world-leading gene control research and drug discovery capabilities with a proven ability to integrate disease biology and genomic data–a proficiency that is not well represented in pharmaceutical R&D. - Website
http://www.syros.com - Transaction Type
Venture Equity - Transaction Amount
$30,000,000 - Transaction Round
Series A - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
ARCH Venture Partners - Venture Investor
Flagship Ventures - Venture Investor
WuXi PharmaTech - Venture Investor
Undisclosed
